123 related articles for article (PubMed ID: 12558908)
1. The long-term efficacy of plasma-derived hepatitis B vaccine in babies born to carrier mothers.
Young BW; Lee SS; Lim WL; Yeoh EK
J Viral Hepat; 2003 Jan; 10(1):23-30. PubMed ID: 12558908
[TBL] [Abstract][Full Text] [Related]
2. Long-term immunogenicity and efficacy of hepatitis B vaccine in infants born to HBeAg-positive HBsAg-carrier mothers.
Lo KJ; Lee SD; Tsai YT; Wu TC; Chan CY; Chen GH; Yeh CL
Hepatology; 1988; 8(6):1647-50. PubMed ID: 3192179
[TBL] [Abstract][Full Text] [Related]
3. Anti-HBs levels in infants of hepatitis B carrier mothers after delayed active immunization with recombinant vaccine concomitant with DTP-polio vaccine: is there need for a second dose of HBIg? Dutch Study Group on Prevention of Neonatal Hepatitis B.
Grosheide PM; del Canho R; Voogd M; Heijtink RA; Schalm SW
Vaccine; 1994 Sep; 12(12):1059-63. PubMed ID: 7998413
[TBL] [Abstract][Full Text] [Related]
4. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.
Tsebe KV; Burnett RJ; Hlungwani NP; Sibara MM; Venter PA; Mphahlele MJ
Vaccine; 2001 Jul; 19(28-29):3919-26. PubMed ID: 11427266
[TBL] [Abstract][Full Text] [Related]
5. Immunoprophylaxis of perinatal transmission of the hepatitis B virus: efficacy of hepatitis B immune globulin and hepatitis B vaccine in a low-prevalence area.
Esteban JI; Genesca J; Esteban R; Hernandez JM; Seijo G; Buti M; Muniz R; Guardia J
J Med Virol; 1986 Apr; 18(4):381-91. PubMed ID: 2940334
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a low dose of hepatitis B vaccine given within a childhood immunisation programme in Singapore.
Oon CJ; Tan KL; Goh KT; Wong-Yong L; Viegas O; McCarthy T; Chan SH; Lee HP
J Infect; 1986 Nov; 13(3):255-67. PubMed ID: 2947953
[TBL] [Abstract][Full Text] [Related]
7. An efficacy trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine in infants born to mothers positive for HBsAg, in Shanghai, China.
Halliday ML; Kang LY; Rankin JG; Coates RA; Corey PN; Hu ZH; Zhou TK; Yuan GJ; Yao FL
Int J Epidemiol; 1992 Jun; 21(3):564-73. PubMed ID: 1386063
[TBL] [Abstract][Full Text] [Related]
8. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study.
Wong VC; Ip HM; Reesink HW; Lelie PN; Reerink-Brongers EE; Yeung CY; Ma HK
Lancet; 1984 Apr; 1(8383):921-6. PubMed ID: 6143868
[TBL] [Abstract][Full Text] [Related]
9. Duration of immune protection after hepatitis B vaccine in newborns from HBsAg-positive carrier mothers.
Belloni C; Orsolini P; Soldini L; Campisi D; Chiesa A; Ciceri R; Filice G
Microbiologica; 1991 Jul; 14(3):195-8. PubMed ID: 1833611
[TBL] [Abstract][Full Text] [Related]
10. Multicenter trial on the efficacy of HBIG and vaccine in preventing perinatal hepatitis B. Final report.
Zanetti AR; Dentico P; Del Vecchio Blanco C; Sagnelli E; Villa E; Ferroni P; Bergamini F
J Med Virol; 1986 Apr; 18(4):327-34. PubMed ID: 2940333
[TBL] [Abstract][Full Text] [Related]
11. A six-year survey of immunogenicity and efficacy of hepatitis B vaccine in infants born to HBsAg carriers.
Zhu QR; Duan SC; Xu HF
Chin Med J (Engl); 1992 Mar; 105(3):194-8. PubMed ID: 1395837
[TBL] [Abstract][Full Text] [Related]
12. The protective efficacy of recombinant hepatitis B vaccine in newborn infants of hepatitis B e antigen-positive-hepatitis B surface antigen carrier mothers.
Lee CY; Huang LM; Chang MH; Hsu CY; Wu SJ; Sung JL; Safary A
Pediatr Infect Dis J; 1991 Apr; 10(4):299-303. PubMed ID: 1829515
[TBL] [Abstract][Full Text] [Related]
13. Impact of maternal carrier status on immunologic markers for protection after hepatitis B vaccination in infancy: a meta-analysis.
Schönberger K; Riedel C; Rückinger S; Mansmann U; Jilg W; von Kries R
Vaccine; 2012 Sep; 30(44):6314-26. PubMed ID: 22885275
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.
Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH
Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584
[TBL] [Abstract][Full Text] [Related]
15. Vaccination against hepatitis B virus infection in neonates.
Pongpipat D; Suvatte V; Assateerawatts A
Helv Paediatr Acta; 1984 Aug; 39(3):231-6. PubMed ID: 6242403
[TBL] [Abstract][Full Text] [Related]
16. [Immune response to hepatitis B vaccine in neonates born to mothers with various infection status of hepatitis B virus].
Yin SR
Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Aug; 10(4):198-202. PubMed ID: 2805044
[TBL] [Abstract][Full Text] [Related]
17. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.
Wang F; Zhang G; Zheng H; Miao N; Shen L; Wang F; Dong P; Du F; Chen C; Zhang X; Cui F
Vaccine; 2017 Jul; 35(33):4229-4235. PubMed ID: 28651839
[TBL] [Abstract][Full Text] [Related]
18. Role of hepatitis B immunoglobulin in infants born to hepatitis B e antigen-negative carrier mothers in Taiwan.
Yang YJ; Liu CC; Chen TJ; Lee MF; Chen SH; Shih HH; Chang MH
Pediatr Infect Dis J; 2003 Jul; 22(7):584-8. PubMed ID: 12867831
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of the immunogenicity of yeast-derived (recombinant) and plasma-derived hepatitis B vaccine in infants.
Panda SK; Ramesh R; Rao KV; Gupta A; Zuckerman AJ; Nayak NC
J Med Virol; 1991 Dec; 35(4):297-302. PubMed ID: 1802958
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B vaccine alone or in combination with anti-HBs immunoglobulin in the perinatal prophylaxis of babies born to HBsAg carrier mothers.
Sehgal A; Gupta I; Sehgal R; Ganguly NK
Acta Virol; 1992 Aug; 36(4):359-66. PubMed ID: 1362320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
